Apellis Pharmaceuticals
Price & Volume
Stats
See more52W Range | $21.70-$57.85 |
Market Cap | $2.8B |
Shares Short | 19M |
Financials
See moreRevenue (12 Mos) | $781.3M |
Revenue Growth (YoY) | 45.2% |
Gross Profit (12 Mos) | $336M |
Diluted EPS | -$1.60 |
News
See moreYahoo Finance • 4 days ago
Apellis Announces FDA Acceptance and Priority Review of the Supplemental New Drug Application for EMPAVELI® (pegcetacoplan) for C3G and Primary IC-MPGN
Yahoo Finance • last month
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results
Yahoo Finance • last month
Apellis Pharmaceuticals to Present at the TD Cowen 45th Annual Health Care Conference
About
CEO | Dr. Cedric Francois M.D., Ph.D. |
CFO | Mr. Timothy E. Sullivan |
Address | 100 Fifth Avenue, Waltham, MA, United States, 02451 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 705 |
